Drugs Made In America Acquisition (DMAA) Stock Price, News & Analysis

Company Overview

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099.

Key Stats

• Today's Range: $10.26 to $10.27
• 50-Day Range: N/A
• 52-Week Range: $9.95 to $10.28
• Volume: 77,011 shs
• Average Volume: 31,028 shs
• Market Capitalization: $299.28 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DMAA Stock Analysis - Frequently Asked Questions

How have DMAA shares performed this year?

Drugs Made In America Acquisition's stock was trading at $10.26 at the start of the year. Since then, DMAA stock has increased by 0.0% and is now trading at $10.26.

Who are Drugs Made In America Acquisition's major shareholders?

Drugs Made In America Acquisition's top institutional shareholders include Wolverine Asset Management LLC (3.50%).

How do I buy shares of Drugs Made In America Acquisition?

Shares of DMAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Financial Services
• Industry: Investment Offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:DMAA
• CIK: 2028614
• Web: N/A
• Phone: (954) 870-3104
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 29,170,000
• Free Float: N/A
• Market Cap: $299.28 million
• Optionable: N/A
• Beta: N/A